PMC:7537300
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T1 | 26-32 | Body_part | denotes | genome | http://purl.org/sig/ont/fma/fma84116 |
T2 | 111-121 | Body_part | denotes | nucleotide | http://purl.org/sig/ont/fma/fma82740 |
T3 | 326-332 | Body_part | denotes | genome | http://purl.org/sig/ont/fma/fma84116 |
T4 | 542-549 | Body_part | denotes | genomes | http://purl.org/sig/ont/fma/fma84116 |
T5 | 586-590 | Body_part | denotes | gene | http://purl.org/sig/ont/fma/fma74402 |
T6 | 774-784 | Body_part | denotes | amino acid | http://purl.org/sig/ont/fma/fma82739 |
T7 | 880-888 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
T8 | 1447-1449 | Body_part | denotes | H3 | http://purl.org/sig/ont/fma/fma84131 |
T9 | 1657-1667 | Body_part | denotes | nucleotide | http://purl.org/sig/ont/fma/fma82740 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 15-19 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T2 | 166-170 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T3 | 315-319 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 203-209 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | humans |
T2 | 267-270 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T3 | 429-434 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T4 | 536-541 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T5 | 586-590 | http://purl.obolibrary.org/obo/OGG_0000000002 | denotes | gene |
T6 | 862-867 | http://purl.obolibrary.org/obo/OGG_0000000002 | denotes | genes |
T7 | 944-945 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
T8 | 1120-1127 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | viruses |
T9 | 1540-1541 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T1 | 111-121 | Chemical | denotes | nucleotide | http://purl.obolibrary.org/obo/CHEBI_36976 |
T2 | 774-784 | Chemical | denotes | amino acid | http://purl.obolibrary.org/obo/CHEBI_33709 |
T3 | 774-779 | Chemical | denotes | amino | http://purl.obolibrary.org/obo/CHEBI_46882 |
T4 | 780-784 | Chemical | denotes | acid | http://purl.obolibrary.org/obo/CHEBI_37527 |
T5 | 880-888 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
T6 | 1657-1667 | Chemical | denotes | nucleotide | http://purl.obolibrary.org/obo/CHEBI_36976 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id | tao:has_standard_notation |
---|---|---|---|---|---|---|
2 | 107-110 | Gene | denotes | Tag | Gene:404663 | |
3 | 15-25 | Species | denotes | SARS‐CoV‐2 | Tax:2697049 | |
10 | 913-918 | Gene | denotes | ORF3a | Gene:43740569 | |
11 | 1718-1721 | Gene | denotes | Tag | Gene:404663 | |
12 | 166-176 | Species | denotes | SARS‐CoV‐2 | Tax:2697049 | |
13 | 203-209 | Species | denotes | humans | Tax:9606 | |
14 | 315-325 | Species | denotes | SARS‐CoV‐2 | Tax:2697049 | |
15 | 971-980 | Mutation | denotes | Asp614Gly | p.D614G |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-132 | Sentence | denotes | 11Evolution of SARS‐CoV‐2 genome from December 2019 to late March 2020: emerged haplotypes and informative Tag nucleotide variations |
T2 | 133-146 | Sentence | denotes | SAFARI et al. |
T3 | 148-156 | Sentence | denotes | Abstract |
T4 | 157-165 | Sentence | denotes | Abstract |
T5 | 166-210 | Sentence | denotes | SARS‐CoV‐2 causes serious disease in humans. |
T6 | 211-297 | Sentence | denotes | First identified in November/December 2019 in China, it has rapidly spread world‐wide. |
T7 | 298-476 | Sentence | denotes | We analyzed 2790 SARS‐CoV‐2 genome sequences from 56 countries that were available on April 2, 2020 to assess the evolution of the virus during this early phase of its expansion. |
T8 | 477-591 | Sentence | denotes | We aimed to assess sequence variations that had evolved in virus genomes, giving greatest attention to the S gene. |
T9 | 592-719 | Sentence | denotes | We also aimed to identify haplotypes that the variations may define and consider their geographic and chronologic distribution. |
T10 | 720-809 | Sentence | denotes | Variations at 1930 positions that together cause 1203 amino acid changes were identified. |
T11 | 810-943 | Sentence | denotes | The frequencies of changes normalized to lengths of genes and encoded proteins were relatively high in ORF3a and relatively low in M. |
T12 | 944-1148 | Sentence | denotes | A variation that causes an Asp614Gly near the receptor binding domain of S was found at high frequencies, and it was considered that this may contribute to the rapid spread of viruses with this variation. |
T13 | 1149-1198 | Sentence | denotes | Our most important findings relate to haplotypes. |
T14 | 1199-1367 | Sentence | denotes | Sixty‐six haplotypes that constitute thirteen haplotype groups (H1‐H13) were identified, and 84.6% of the 2790 sequences analyzed were associated with these haplotypes. |
T15 | 1368-1450 | Sentence | denotes | The majority of the sequences (75.1%) were associated with haplotype groups H1‐H3. |
T16 | 1451-1539 | Sentence | denotes | The distribution pattern of the haplotype groups differed in various geographic regions. |
T17 | 1540-1578 | Sentence | denotes | A few were country/territory specific. |
T18 | 1579-1643 | Sentence | denotes | Location and time of emergence of some haplotypes are discussed. |
T19 | 1644-1779 | Sentence | denotes | Importantly, nucleotide variations that define the various haplotypes and Tag/signature variations for most of haplotypes are reported. |
T20 | 1780-1841 | Sentence | denotes | The practical applications of these variations are discussed. |
T21 | 1842-1881 | Sentence | denotes | This article is protected by copyright. |
T22 | 1882-1902 | Sentence | denotes | All rights reserved. |